New eye drop shows fast relief for dry eye sufferers

NCT ID NCT06309953

Completed Symptom relief Sponsor: Bausch & Lomb Incorporated Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times

Summary

This study tested a new eye drop called Miebo™ in 99 adults with dry eye disease. The goal was to see if symptoms improve within one week of starting treatment. Participants used the eye drops and reported their symptom severity on a scale from 0 (none) to 100 (worst). The study is complete and results will show how well Miebo™ works for early symptom relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Site 201

Brecksville, Ohio, 44141, United States
Site 202

Kansas City, Missouri, 64154, United States
Site 203

Pittsburg, Kansas, 66762, United States
Site 204

Stillwater, Minnesota, 55082, United States
Site 205

Petaluma, California, 94954, United States
Site 206

Westlake, Ohio, 44145, United States
Site 207

Birmingham, Alabama, 35233, United States

Conditions

Explore the condition pages connected to this study.

DRY EYE